During the Vancouver edition of the International Cannabis Business Conference (ICBC) on Monday (June 25) an strategic advisory executive and investment advisor hosted a panel describing the shortfalls of the upcoming landscape of the cannabis public markets in Canada.

Nic Easley, acting as the CEO of 3C Consulting and a managing partner with Multiverse Capital, oversees and provides strategic advisory to clients of the consulting firm and investment guidance.

The Investing News Network (INN) had the opportunity to catch up with Easley on why exactly he calls a predicted cannabis bubble burst even worse than the dotcom bubble and where investors should be looking at in order to be prepared for this event.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Diversification will be key for cannabis investors

On his panel Easley emphasized companies needed to look at diversification. In speaking to INN, he expanded on how investors can keep up with this company necessity:

If you like a particular sector like let’s say a cultivator, I like to know everything that they are using. I like to know everyone they are selling to and I like to know where else in that supply chain can I make that investment … and also make other investments to capture pieces of that supply chain.

Easley explained ancillary businesses adjacent to the overall cannabis sector are poised to see growth alongside the booming market, in some cases even higher according to him.

With the exponential growth the cannabis industry has seen, a variety of generalist investors have gotten caught up with the enthusiasm surrounding the the sector. Easley, however, recommends investors to not being too brunt, too fast or too early.

“Diversifying within a sector is nice but if you buy 50 cannabis stock companies, it’s a bad idea because there’s not 50 good ones. Even if you buy the top 10 that’s not a good thing either,” Easley said.

Dotcom Bubble scenario incoming for the cannabis sector?

“The bubble is caused for all the speculation and all the international markets that they can sell things to,” Easley said. He added this leads to a “curve of disillusion” from rising potential.

“We’re realizing the cost of production here is extremely high and there’s a lot of them where a lot of cap has been invested into mass production [when] it’s about to be mildly constrained,” he said.

During his panel the executive said the bubble for the public cannabis market was three times worse than the dotcom bubble.

Other observers of the industry–and active players as well–have disagreed with the comparison to the crushing dotcom bubble.

In an interview with BNN Bloomberg, Aurora Cannabis (TSX:ACB) CEO Terry Booth said the cannabis space will continue to exist and it is merely starting to bring people in.

“I don’t have any concerns whatsoever about a dotcom bubble,” Booth said during the televised segment.

Rob Tétrault, a portfolio manager and head of the Tetrault Wealth Advisory Group with Canaccord Genuity, told Vice News in January cannabis ventures are not able to create new previously non-existing value streams.

When asked how investors can be better prepared when facing his predicted gloomy scenario, Easley told INN public market investors should look at who has a leading position, the companies that delivering on promises and are in positions to obtain licenses while expanding into other markets.

He added investors should know if their picks have partnerships in “different revenue streams.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence. 


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less